Skip to main content

Maria Martell Pérez-Alcalde

I am a senior researcher, PhD in Biology, coordinator of the Advanced Chronic Liver Disease Laboratory of the Liver Diseases Research Group at the Vall d'Hebron Institut of Research Hospital Research Institute (VHIR).

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca
Hepatologia
General Hospital

Maria Martell Pérez-Alcalde

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca
Hepatologia
General Hospital

I am a senior researcher, PhD in Biology, coordinator of the Advanced Chronic Liver Disease Laboratory of the Liver Diseases Research Group at the Vall d'Hebron Institut of Research Hospital Research Institute (VHIR).

I am a senior researcher, PhD in Biology, coordinator of the Advanced Chronic Liver Disease Laboratory of the Liver Diseases Research Group at the Vall d'Hebron Institut of Research Hospital Research Institute (VHIR).

Projects

Estudio longitudinal de la expresión génica diferencial de la alteración vascular esplácnica en el modelo experimental de hipertensión portal de rata. Papel de los mecanismos de angiogénesis

IP: Joan Genescà Ferrer
Collaborators: Antonio González Fernández, Maria Nieves Martell Pérez-Alcalde
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 83490
Reference: SAF2006-03714
Duration: 01/10/2006 - 30/09/2009

Ministerio de Ciencia

Efecto de la variabilidad genética en la región NS3 del Virus de la hepatitis C (VHC) sobre maduración y presentación de proteínas recombinantes aislado-específicas de células dendríticas autólogas.

IP: -
Collaborators: Silvia Sauleda Oliveras, Josep Quer Sivila, Maria Nieves Martell Pérez-Alcalde, Juan Ignacio Esteban Mur
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 164600
Reference: SAF2003-08724
Duration: 15/12/2003 - 15/12/2006

Ministerio de Ciencia

Conservación de la estructura del rna y accesibilidad a la rnasa p en dos motivos del rna genómico del virus de la hepatitis c para una nueva terapia antiviral.

IP: -
Collaborators: Maria Nieves Martell Pérez-Alcalde, Maria Madeleine Piron
Funding agency: Instituto de Salud Carlos III
Funding: 72722.46
Reference: 01/1351
Duration: 17/07/2001 - 31/12/2003

Related news

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

Related professionals

Josefa Mª Heredia Montiel

Josefa Mª Heredia Montiel

Administration and Management
Physiology and Pathophysiology of the Digestive Tract
Read more
Luis Carrera Calderer

Luis Carrera Calderer

Reconstructive Surgery of the Locomotor System
Read more
Nuria Nogués Gálvez

Nuria Nogués Gálvez

Transfusional Medicine
Read more
Anna González Tallada

Anna González Tallada

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.